Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use

NEW YORK, NY JUNE 16, 2009 The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June 15 in the journal Circulation . The study also co...

NEJM study finds drug-eluting stents more effective than bare-metal stents in heart attack patients

NEW YORK (May 26, 2009) -- NewYork-Presbyterian Hospital and Columbia University Medical Center, together with the Cardiovascular Research Foundation (CRF), announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published in the May 7 ...

CorNova to Present at the Glimpse into the Future: Emerging Drug-Eluting Stents Symposium at EuroPCR 2009

S. Eric Ryan, M.D., Will Discuss the Valecor Platinum(TM) Coronary Stent System on the FiberHalo(TM) Balloon Angioplasty Catheter BURLINGTON, Mass., May 14 /PRNewswire/ -- CorNova Inc. today announced S. Eric Ryan, M.D., the company's chairman and chief executive officer, will present the Val...

Drug-Coated Stents Better at Keeping Arteries Open

But they show no lifesaving benefit over bare-metal version, studies show WEDNESDAY, May 6 (HealthDay News) -- Although arteries propped open by drug-coated stents are less likely to become blocked again than those treated with bare-metal stents, the risk of death and heart attacks is...

Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed

NATICK, Mass., March 31 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent litigation with Johnson and Johnson (J&J). The Court of Appeals upheld the District C...

No Increase in Clots With Drug-Eluting Stents

Risk appears the same for bare metal or drug-eluting devices, study found,, SUNDAY, March 29 (HealthDay News) -- Despite initial concerns that stent thrombosis, a blood clot inside a stent, is more common with the drug-eluting device, there appears to be no difference in the clot risk ...

Drug-eluting stents found safe, superior to bare metal stents

DURHAM, NC Drug-eluting stents were safe and superior to bare metal stents in preventing death and heart attacks among 262,700 "real-world" patients enrolled in a nationwide registry of cardiovascular disease, according to researchers from Duke University Medical Center. The findings were pre...

Bioabsorbable stents show promise

A study published today online in The Lancet (March 13, 2009) presented two year data for the bioabsorbable everolimus coronary stent. Commenting on the results, interventional cardiology specialist, Professor Franz Eberli from the University Hospital Zurich (Switzerland) and official spokespers...

Drugs Before Stents for Stable Heart Disease, Study Says

Most important, expert says, is to aggressively try to reduce risk factors,,,,,, THURSDAY, March 12 (HealthDay News) -- Treating people with non-acute heart problems should start with drug therapy, not invasive techniques such as angioplasty or implanting stents, because there is no di...

Drug-Eluting Stents Show Promise for Leg Arteries

Fewer repeat procedures were needed in people with peripheral arterial disease, study finds,, TUESDAY, March 10 (HealthDay News) -- Treating peripheral arterial disease with drug-eluting stents may save lives and limbs in people with severely obstructed arteries, Greek researchers have...

More>>

Stents in Medical Technology

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

NATICK, Mass. and ORLANDO, Fla., March 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that while the overall cost ...

New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease

BALTIMORE, Jan. 27 /PRNewswire/ -- Most Americans know their cholesterol level, but do they know how "sticky" their platelets are? Research findings from Dr. Paul A. Gurbel, an interventional cardiologist and Director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimor...

HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients

Landmark trial provides new insight for physicians NATICK, Mass. and WASHINGTON, Oct. 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of the HORIZONS AMI trial. The HORIZONS AMI trial, sponsored by the Cardiovascular ...

SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery

New SYNTAX Score shows similar safety and efficacy outcomes for two thirds of study's patients NATICK, Mass. and WASHINGTON, Oct. 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced 12-month left main and three-vessel disease subset ...

Large Study Gives Nod to Drug-Eluting Stents in Heart Attack

Arterial renarrowing less likely, with no increase in mortality on long-term follow-up CHICAGO, March 30 /PRNewswire/ -- Although drug-eluting stents have become widely used for the treatment of stable coronary artery disease, many cardiologists choose bare-metal st...

Drug-Eluting Stents Outperform Bare Stents in Heart Attack

Anti-clotting drug tirofiban also edges abciximab CHICAGO, March 30 /PRNewswire/ -- New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-seg...

OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial

NAPLES, Italy, Jan. 10 /PRNewswire/ -- Patients who received OrbusNeich's pro-healing stent, the Genous Bio-engineered R stent, had significantly fewer major cardiac adverse events (MACE) than patients who received Boston Scientific's TAXUS or Johnson & Johnson's CYPHER drug-eluting stents in ...

Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures

NATICK, Mass., and WASHINGTON, Oct. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed results from the SPIRIT III Clinical Trial, which continue to support the proven safety and efficacy of the market-leading TAXUS(R) Express2(TM) Paclitaxel-Eluting Corona...

Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety

VIENNA, Austria, Sept. 3 /PRNewswire/ -- Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) reported today that the CYPHER(R) Sirolimus-eluting Coronary Stent continued to provide clinical benefits compared to a bare metal stent in the E-SIRIUS Trial...

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

Other Presentations Highlight Pre-clinical Work of Company's Future Pro-healing Technologies BARCELONA, Spain, May 20 /PRNewswire/ -- OrbusNeich announced today that two year follow up data from a single center, randomized clinical study in patients at high risk of restenosis were presented a...

Stents in Medical Products

Silicone Universal Drainage Stents

Description: Used for stenting the urethra during hypospadias or epispadias repair and to promote postoperative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Company:Cook Urological

Firlit-Kluge Urethral Stents

Description: Used for stenting the urethra during hypospadias or epispadias repair and to allow post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Company:Cook Urological

Koyle Diaper Stents

Description: Used for stenting the urethra after hypospadias or epispadias repair and to provide postoperative drainage of the bladder. The externalized portion of the stent is of sufficient length to allow drainage into a second or outside diaper, keeping the inside diaper dry during the healing process. Suppl...
Company:Cook Urological

Zaontz Urethral Stents

Description: Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Company:Cook Urological

UroPass® Open Tip Ureteral Stents

Description: UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
Company:GYRUS ACMI

UroPass® II Open Tip Ureteral Stents

Description: UroPass II Open Tip Ureteral Stents have all the advantages and benefits of the UroPass. In addition, a unique 360 degree kidney curl helps to achieve easier stent placement in the renal pelvis or a calyx. The result is a remarkably comfortable stent, ideal for use in smaller kidneys....
Company:GYRUS ACMI

Uro-Guide™ Open Tip Ureteral Stents

Description: ACMI™ Uro-Guide Open Tip Ureteral Stents were the first silicone over-the-wire stents and have a classic Double-J design with an open tip. They are composed of time-tested biocompatible silicone material, which provides maximum patient comfort while minimizing stent encrustation....
Company:GYRUS ACMI

Multi-Flex™ Open Tip Ureteral Stents

Description: Multi-Flex Open Tip Ureteral Stents feature teardrop shaped kidney curls for enhanced stability, long tapered tips and hydrophilic coating for ease of placement, and helix kidney curls for minimized irritation to the trigone. The Multi-Flex advanced design has two material durometers - a firmer kid...
Company:GYRUS ACMI

Lubri-Flex® Open Tip Ureteral Stents

Description: Lubri-Flex Open Tip Ureteral Stents combine a unique polymer material that softens at body temperature while remembering its shape with a chemically bonded wettable solution that becomes ultra-slippery when moistened. The result is a stent that satisfies the need for ease of placement and patient c...
Company:GYRUS ACMI

Classic Open Tip Ureteral Stents

Description: All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
Company:GYRUS ACMI

More>>

Stents in Medical Dictionary

Stent

...t narrowed or weakened arteries in the body. You may have a stent placed in an artery as part of a procedure called ... Describes drug-coated stents that gradually release a drug to prevent or reduce restenosis, a condition in which a blood vessel recloses over the stent . Brief and Strai...

PPD skin test

...for tuberculosis. ... people infected with tuberculosis may not have a reaction on the PPD skin test . ... PPD skin test . VIDEO: Lung stents help asthmatics to breathe easier ... Inform your health care provider if you have ever had a positive PPD skin test . ... ... derivative sta...

Pleural fluid analysis

...es fluid that ... A procedure called thoracentesis is used to get a sample of pleural fluid . ... Pleural fluid analysis . VIDEO: Lung stents help asthmatics to breathe easier ... Pleural fluid analysis . Definition: Pleural fluid analysis examines fluid that ... Thoracentes...

Chest tube insertion

...ou. relax. ... chest tube insertion . Your doctor will make a small cut and put. in the chest ... Chest tube insertion . VIDEO: Lung stents help asthmatics to breathe easier ... Chest tube insertion . Definition: Surgical insertion of a hollow, flexible ... Surgical insertion ...

Asbestosis

...ed exposure to large quantities of ... Asbestosis is most common in men over 40 who have worked in asbestos-related occupations. ... VIDEO: Lung stents help asthmatics to breathe easier ... Asbestosis . Definition: Asbestosis is a respiratory disease caused by inhaling asbestos fibers. ... ...

Angioplasty

...on angioplasty , atherectomy, and stent placement. Angioplasty and stents are commonly used to treat heart disease today. Learn more about them. ...angioplasty . ... Balloon angioplasty . ... Coronary angioplasty and stents — Overview covers definition and results of this heart procedure. ... An...

Stents in Biological News

Promising 3-year data: Saving limbs with drug-eluting stents

SAN DIEGO, Calif. (March 10, 2009)Attempts to treat critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty are still thwarted by restenosis (the re-narrowing of the artery at the site of angioplasty or stenting), the need for repeat treatments and the ...

Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies

Improved materials may allow stents, tiny metal scaffolds inserted into blood vessels, to better deliver beneficial genes to patients with heart disease, by reducing the risk of inflammation that often negates initial benefits. The new technique, using a compound that binds in an extremely thin lay...

Society of Interventional Radiology hosts 34th annual scientific meeting

... (Embargoed for release until Tuesday, March 10, 2009, 9 a.m. Eastern) B-roll and illustrations are available. Seeing the Promise of Drug-Eluting stents for Critical Limb Ischemia Interventional radiologists are helping peripheral arterial disease (PAD) patients with critical limb ischemia avoid amput...

Franklin Square to study airway bypass procedure for severe emphysema

...nklin Square Hospital Center announces the start of the EASE (Exhale Airway stents for Emphysema) Trial to explore an investigational treatment for advanced w... airway. These pathways are supported and kept open by Exhale Drug-Eluting stents manufactured by Broncus Technologies, Inc. Patients could see an immediat...

National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier

...and overinflated with air that cannot escape. The holes, kept open by small stents inserted during a minimally invasive procedure, could relieve the hyperinfl...l airway. These pathways are supported and kept open by Exhale Drug-Eluting stents manufactured by Broncus Technologies, Inc. "Airway bypass is groundbre...

Researchers at National Jewish Health evaluating a treatment

...and overinflated with air that cannot escape. The holes, kept open by small stents inserted during a minimally invasive procedure, could relieve the hyperinfl...l airway. These pathways are supported and kept open by Exhale Drug-Eluting stents manufactured by Broncus Technologies, Inc. "Airway bypass is groundbre...

UCSF Fresno leading-edge study lends hope to emphysema patients

... Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways stents for Emphysema (EASE) trial. The trial principal is Dr. Karl Van Gundy aided by investigators Drs. Michael Peterson, Jose Joseph, Timothy Evans and Kat...

12-month ATLANTA trial data show sustained benefit of Catania Stent

...d complete endothelialization and 99.5 percent stent strut coverage. "Every clinician is aware of the questions and issues surrounding drug-eluting stents and the increased risk of late and very late stent thrombosis, malapposition, inflammatory or hypersensitivity reactions, as well as the economic impa...

Sentara begins international trial -- open at only 24 US locations

...l study to explore the safety and effectiveness of stents to open airways of patients with advanced emphysem...monary Disease (COPD). The EASE (Exhale Airway stents for Emphysema) Trial focuses on airway bypass, an ...pread emphysema breathe easier. Similar to the stents used to prop open clogged arteries in heart patien...

Project aims to reduce complications, multiple surgeries with biodegradable implantable devices

...us, magnesium alloys dissolve after their work is done with no clinical side effects, a feature also beneficial in the cardiovascular realm. Magnesium stents and other supports would restore cardiovascular function without having to remove the device and without exposing the patient to the potential complic...

Stents in Biological Technology

Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons

Company In-licenses State-of-the-art CE-Marked Cobalt-Chromium Coronary Stent Forms Alliance to Jointly Develop Drug Eluting Balloon Products RALEIGH, N.C., Jan. 12 /PRNewswire/ -- Micell Technologies announced today that that the company entered into a strategic agreement with Maxcor In...

Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery

NATICK, Mass. and MUNICH, Germany, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced one-year data from its landmark SYNTAX trial comparing percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent Sys...

WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents

NATICK, Mass., May 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its ruling in an arbitration between the Company and Medinol, Ltd. Medinol, which had requested the arb...

NanoInterventions Launches New, Rapid Testing System for Coronary Stents

Two Minnesota bio-science companies, The Integra Group of Brooklyn Park and Nanocopoeia of St. Paul, team in a global effort to speed the path to market for advances in cardiovascular medicine BROOKLYN PARK, Minn. and SAN DIEGO, June 17 /PRNewswire/ -- Coinciding with the BIO Inte...

Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

PROENCY will provide real-world clinical data on the PROMUS(TM) Stent NATICK, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the first patient has been enrolled in its PROENCY (PROMUS(TM), ENdeavor(R) and CYpher(R)) European registry....

PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents

WASHINGTON, Dec. 13 /PRNewswire/ -- Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation. This is a crucial message in a guideline update published online today i...

Medical College discovery leads to new stents

MILWAUKEE An investigation of how blood flows through stents after opening clogged arteries has led a team of researchers at the Medical College of Wisconsin Cardiovascular Center in Milwaukee to suggest that stents designed with thinner and fewer linkages may be the basis of a new generation of...

Health-care eyes focus on San Francisco, war of the stents

The talk of the town (the town being San Francisco, which kicks of the JP Morgan Annual Healthcare Conference on Monday) will most likely be the news from Sunday and early Monday that the Johnson & Johnson acquisition of Guidant for $22 billion is once again no longer a done deal. On Sunday, B...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...t systems incorporating the drug paclitaxel. TAXUS stents have been evaluated by the industry's most extensi...egistries. To date, approximately 11 million TAXUS stents have been implanted globally, making them the worl...nts. Royalty revenue derived from sales of TAXUS stents by BSC for the second quarter of 2009 decreased by...

PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices

...ponses of biological systems to known load conditions and will use HyperWorks to model medical devices for various applications, ranging from coronary stents to orthopedics implant. "We were looking for a high-performance finite element analysis tool to assess mechanical resistance limits in relatio...